Related Experiment Video
Updated: Jul 10, 2026

Transfection, Selection, and Colony-picking of Human Induced Pluripotent Stem Cells TALEN-targeted with a GFP Gene into the AAVS1 Safe Harbor
Published on: February 1, 2015
Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration
Joseph R Smith1, Sean Maguire, Lesley A Davis
1Department of Surgery, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Addenbrooke's Hospital, Hills Road, Cambridge CB2 OXY, United Kingdom. jrs68@cam.ac.uk
Targeting the AAVS1 locus in human embryonic stem cells (hESCs) with adeno-associated virus type 2 (AAV2) technology improves transgene expression stability. This method reduces silencing and variegation, crucial for reliable gene function studies and potential clinical applications.
Area of Science:
- Stem Cell Biology
- Gene Therapy
- Molecular Biology
Background:
- Silencing and variegated transgene expression pose challenges in human embryonic stem cell (hESC) gene function studies.
- Random transgene integration in hESCs leads to unstable expression, often lost during differentiation or after selection withdrawal.
Purpose of the Study:
- To investigate the hypothesis that integrating transgenes into the adeno-associated virus type 2 (AAV2) target site (AAVS1 locus) on chromosome 19 enhances stable transgene expression in hESCs.
- To evaluate the impact of AAVS1 locus targeting on transgene expression stability, variegation, and silencing compared to random integration.
Main Methods:
- Utilized AAV2 technology for targeted integration of enhanced green fluorescent protein (EGFP) transgene into the AAVS1 locus in hESCs.
- Assessed targeted integration efficiency, pluripotency marker expression (Oct-4, SSEA3, Tra-1-60), differentiation potential, and EGFP expression levels via flow cytometry and quantitative PCR.
- Compared EGFP expression stability, variegation, and silencing in AAVS1-targeted clones versus randomly integrated controls during selection, post-selection withdrawal, and differentiation.
Main Results:
- Achieved AAVS1-targeted integration in 4.16% of hESC clones, which maintained pluripotency and differentiated into all three germ layers.
- AAVS1-targeted EGFP expression showed significantly reduced variegation (90% vs. 57%) and silencing (86% vs. 39% after 25 days) compared to random integration.
- Quantitative PCR confirmed higher EGFP mRNA levels in targeted clones, and transgene expression remained stable (>90%) during 15 days of hESC differentiation.
Conclusions:
- Integration at the AAVS1 locus using AAV2 technology provides a robust method for achieving stable and consistent transgene expression in hESCs.
- This targeted approach overcomes limitations of random integration, offering utility for gene function studies and potential clinical applications in regenerative medicine.
More Related Videos
11:36Rapid and Efficient Generation of Recombinant Human Pluripotent Stem Cells by Recombinase-mediated Cassette Exchange in the AAVS1 Locus
Published on: November 20, 2016
06:41Transgene Expression in Cultured Cells Using Unpurified Recombinant Adeno-Associated Viral Vectors
Published on: October 20, 2023